Hyperfine, Inc. (HYPR): Price and Financial Metrics
HYPR Price/Volume Stats
| Current price | $1.61 | 52-week high | $2.78 |
| Prev. close | $1.70 | 52-week low | $0.68 |
| Day low | $1.57 | Volume | 99,100 |
| Day high | $1.72 | Avg. volume | 878,787 |
| 50-day MA | $1.41 | Dividend yield | N/A |
| 200-day MA | $1.17 | Market Cap | 114.43M |
HYPR Stock Price Chart Interactive Chart >
HYPR POWR Grades
- Growth is the dimension where HYPR ranks best; there it ranks ahead of 78.65% of US stocks.
- HYPR's strongest trending metric is Growth; it's been moving up over the last 97 days.
- HYPR ranks lowest in Stability; there it ranks in the 6th percentile.
HYPR Stock Summary
- For HYPR, its debt to operating expenses ratio is greater than that reported by merely 0.41% of US equities we're observing.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.08 for HYPERFINE INC; that's greater than it is for merely 8.16% of US stocks.
- As for revenue growth, note that HYPR's revenue has grown 164.23% over the past 12 months; that beats the revenue growth of 95.91% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to HYPERFINE INC, a group of peers worth examining would be NSPR, WISA, AAOI, TTNP, and MRIN.
- To dig deeper into the stock's financial statements, go to HYPR's page on browse-edgar?action=getcompany&CIK=0001833769.
HYPR Valuation Summary
- In comparison to the median Healthcare stock, HYPR's price/sales ratio is 495.24% higher, now standing at 12.5.
- Over the past 28 months, HYPR's price/sales ratio has gone down 642.9.
Below are key valuation metrics over time for HYPR.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| HYPR | 2023-05-15 | 12.5 | 0.9 | -1.6 | 0.1 |
| HYPR | 2023-05-12 | 12.8 | 0.9 | -1.7 | 0.1 |
| HYPR | 2023-05-11 | 12.8 | 0.9 | -1.7 | 0.1 |
| HYPR | 2023-05-10 | 15.1 | 0.8 | -1.4 | 0.2 |
| HYPR | 2023-05-09 | 14.7 | 0.8 | -1.4 | 0.2 |
| HYPR | 2023-05-08 | 15.2 | 0.8 | -1.4 | 0.2 |
Hyperfine, Inc. (HYPR) Company Bio
Hyperfine, Inc. operates as a medical imaging device company. It offers Swoop system, a portable magnetic resonance imaging system. The company was founded in 2014 and is based in Guilford, Connecticut.
Latest HYPR News From Around the Web
Below are the latest news stories about HYPERFINE INC that investors may wish to consider to help them evaluate HYPR as an investment opportunity.
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income CountriesGUILFORD, Conn., May 18, 2023--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced an expansion of clinical research to study the neurological effects of early childhood malnutrition in low and middle-income countries, with funding support from the Bill & Melinda Gates Foundation. The goal of the collaborative, multi-year global study is to address |
Hyperfine, Inc. Reports First Quarter 2023 Financial ResultsGUILFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced first quarter 2023 financial results and provided a business update. “We had strong growth at Hyperfine in the first quarter of 2023 and delivered record revenue of $2.6 million. We remained focused on executing on our three strategic pillars of innovation, clin |
Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023GUILFORD, Conn., April 20, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the first quarter 2023 on Thursday, May 11, 2023. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archive of the presentation will be available thr |
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial ResultsGUILFORD, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™ today announced fourth quarter and full year 2022 financial results and provided a business update. “We made measurable progress at Hyperfine over the past year. We delivered $6.8 million in revenue in 2022, received multiple FDA clearances and international approvals, including CE Marking, |
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system, today announced that it will report financial results for the fourth quarter and full year 2022 on Tuesday, March 21, 2023. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archive of the presentation will b |
HYPR Price Returns
| 1-mo | 10.27% |
| 3-mo | -14.36% |
| 6-mo | 111.87% |
| 1-year | -41.88% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 91.67% |
| 2022 | -88.41% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...